Halofuginone

Products

Halofuginone is commercially available as an oral solution as a veterinary drug. It has been approved in many countries since 2003.

Structure and properties

Halofuginone (C16H17BrClN3O3, Mr = 414.7 g/mol) is a quinazoline derivative.

Effects

Halofuginone (ATCvet QP51AX08) has antiprotozoal properties against .

Indications

For the treatment of diarrhea caused by (cryptosporidiosis) in newborn calves.